Biotheryx Announces Research Collaboration and License Agree

Biotheryx Announces Research Collaboration and License Agreement with Incyte for Discovery of Targeted Protein Degraders for Novel Oncology Targets

/PRNewswire/ -- Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders with a focus on...

Related Keywords

Dashyant Dhanak , Philippe Drouet , Research Collaboration , Prnewswire Biotheryx Inc , Chief Executive Officer , Executive Vice President , Chief Scientific Officer , Biotheryx , Nc ,